A detailed history of Wade G W & Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wade G W & Inc holds 12,639 shares of LLY stock, worth $11.6 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
12,639
Previous 13,429 5.88%
Holding current value
$11.6 Million
Previous $7.21 Million 2.14%
% of portfolio
0.24%
Previous 0.27%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$525.19 - $619.13 $414,900 - $489,112
-790 Reduced 5.88%
12,639 $7.37 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $1.72 Million - $2.36 Million
3,946 Added 41.61%
13,429 $7.21 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $317,770 - $424,895
-906 Reduced 8.72%
9,483 $4.45 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $18,016 - $21,159
-58 Reduced 0.56%
10,389 $3.57 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $5,466 - $6,369
-17 Reduced 0.16%
10,447 $3.82 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $49,215 - $56,086
-166 Reduced 1.56%
10,464 $3.38 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $272,040 - $319,415
976 Added 10.11%
10,630 $3.45 Million
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $258,159 - $320,826
1,100 Added 12.86%
9,654 $2.77 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $96,460 - $119,708
429 Added 5.28%
8,554 $2.36 Million
Q3 2021

Nov 03, 2021

SELL
$221.6 - $272.71 $37,893 - $46,633
-171 Reduced 2.06%
8,125 $1.88 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $340,156 - $439,989
-1,884 Reduced 18.51%
8,296 $1.9 Million
Q1 2021

May 05, 2021

BUY
$164.32 - $212.72 $98,756 - $127,844
601 Added 6.27%
10,180 $1.9 Million
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $78,797 - $104,268
-604 Reduced 5.93%
9,579 $1.62 Million
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $292 - $338
2 Added 0.02%
10,183 $1.51 Million
Q2 2020

Aug 07, 2020

BUY
$136.42 - $164.18 $312,811 - $376,464
2,293 Added 29.07%
10,181 $1.67 Million
Q1 2020

May 06, 2020

SELL
$119.05 - $147.35 $52,143 - $64,539
-438 Reduced 5.26%
7,888 $1.09 Million
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $1,176 - $1,456
11 Added 0.13%
8,326 $1.09 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $53,501 - $58,196
501 Added 6.41%
8,315 $930,000
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $179,036 - $208,981
-1,616 Reduced 17.14%
7,814 $866,000
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $189,449 - $222,996
1,702 Added 22.02%
9,430 $1.22 Million
Q4 2018

Feb 04, 2019

SELL
$105.9 - $118.64 $9,742 - $10,914
-92 Reduced 1.18%
7,728 $894,000
Q3 2018

Nov 07, 2018

BUY
$85.86 - $107.31 $1,459 - $1,824
17 Added 0.22%
7,820 $839,000
Q1 2018

May 04, 2018

BUY
$74.21 - $87.6 $75,026 - $88,563
1,011 Added 14.89%
7,803 $604,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $4,588 - $4,921
-56 Reduced 0.82%
6,792 $574,000
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $527,775 - $585,777
6,848
6,848 $586,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.